KR0152738B1 - Antioxidants and chromosomal disorder inhibitors containing the extracts of ecklonia stolonifera - Google Patents

Antioxidants and chromosomal disorder inhibitors containing the extracts of ecklonia stolonifera

Info

Publication number
KR0152738B1
KR0152738B1 KR1019950043857A KR19950043857A KR0152738B1 KR 0152738 B1 KR0152738 B1 KR 0152738B1 KR 1019950043857 A KR1019950043857 A KR 1019950043857A KR 19950043857 A KR19950043857 A KR 19950043857A KR 0152738 B1 KR0152738 B1 KR 0152738B1
Authority
KR
South Korea
Prior art keywords
gompi
extract
antioxidant
chromosomal
methanol
Prior art date
Application number
KR1019950043857A
Other languages
Korean (ko)
Other versions
KR970025623A (en
Inventor
최재수
이지현
Original Assignee
최재수
이지현
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 최재수, 이지현 filed Critical 최재수
Priority to KR1019950043857A priority Critical patent/KR0152738B1/en
Publication of KR970025623A publication Critical patent/KR970025623A/en
Application granted granted Critical
Publication of KR0152738B1 publication Critical patent/KR0152738B1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/02Algae
    • A61K36/03Phaeophycota or phaeophyta (brown algae), e.g. Fucus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30Extraction of the material
    • A61K2236/33Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/50Methods involving additional extraction steps
    • A61K2236/51Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Chemical & Material Sciences (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

본 발명은 곰피 추출물로된 항산화 및 염색체 이상 억제작용제에 관한 것으로 더욱 자세하게는 곰피의 메탄올추출물이 항산화활성, 프리라디칼소거작용 및 염색체 이상 억제활성이 있음을 밝혀 곰피 추출물의 항산화 및 염색체 이상 억제제로서의 용도에 관한 것이다.The present invention relates to an antioxidant and chromosomal aberration inhibitors of gompi extract. More specifically, the methanol extract of gompi extract has antioxidant activity, free radical scavenging activity and chromosomal aberration inhibitory activity. It is about.

곰피(Ecklonia stolonifera)는 수심 10m 이내의 바위에서 자라는 다시마과에 속하는 갈조류로서 민간에서 식용으로 이용되어지고 있다.Gokpi (Ecklonia stolonifera) is a brown algae belonging to the kelp family that grows on rocks within 10m of depth and is used for edible in civilian.

본 발명은 곰피를 메탄올로 추출한 메탄올 추출물과 그 분획물들의 지질과산화에 대한 항산화 효과를 TBA 측정법(TBA assay)에 의해 실험하고, 또한 1,1-디페닐-2-피크릴히드라질(1,1-diphenyl-2-picry1hydrazy(DPPH))래디칼에 대한 프리래디칼 소거효과를 함께 측정한 결과, 곰피의 메탄올 추출물이 지질의 과산화와 프리래디칼의 소거에 대한 항산화작용을 나타내었고, 또한 실험관내(in vitro)염색체 이상 억제 실험결과 곰피의 메탄올 추출물이 벤조피렌(benzo(a)pyrene)에 의한 염색체 이상 억제효과를 확인하여 노화방지 및 염색체 이상에 의한 질환의 예방에 관한 용도를 제공하는 것이다.The present invention is to examine the antioxidant effect on the lipid peroxidation of methanol extract extracted from gompi methanol and its fractions by TBA assay, and also 1,1-diphenyl-2-picrylhydrazil (1,1 -diphenyl-2-picry1hydrazy (DPPH)) The free radical scavenging effect on radicals was measured. The methanol extract of Gompi showed antioxidant activity against lipid peroxidation and free radical scavenging. Chromosomal Abnormality Inhibition Experimental results show that the methanol extract of Gompi confirms the effect of inhibiting chromosomal abnormality by benzo (a) pyrene and provides the use for the prevention of aging and the prevention of diseases caused by chromosomal abnormalities.

Description

[발명의 명칭][Name of invention]

곰피 추출물로된 항산화 및 염색체 이상 억제제Antioxidant and Chromosome Abnormal Inhibitor with Gompi Extract

[발명의 상세한 설명]Detailed description of the invention

본 발명은 곰피 추출물로된 항산화 및 염색체 이상 억제작용제에 관한 것으로 더욱 자세하게는 곰피의 메탄올추출물이 항산화활성, 프리라디칼소거작용 및 염색체 이상 억제활성이 있음을 밝혀 곰피 추출물의 항산화 및 염색체 이상 억제제로서의 용도에 관한 것이다.The present invention relates to an antioxidant and chromosomal aberration inhibitors of gompi extract. More specifically, the methanol extract of gompi extract has antioxidant activity, free radical scavenging activity and chromosomal aberration inhibitory activity. It is about.

곰피(Ecklonia stolonifera)는 수심 10m이내의 바위에서 자라는 다시마과의 갈조류에 속하는 해조류로서 예로부터 식용으로 이용되어져 왔으며, 일반적으로 해조류들은 민간에서 살충제, 통풍치료제, 항경련제와 담석치료제등으로 널리 이용되어져 왔다. 그동안 곰피에서는 플로로글루시놀(phloroglucinol)과 같은 플로로탄닌(phlorotannin), 에크로니아락톤(ecklonialactone)이 분리, 보고되어져 있지만 그외 다른 성분들에 대한 연구가 거의 이루어져 있지 않은 상태이며, 곰피의 당단백질이 사르코마-180세포(Sarcoma-180 cell)에 대해 항암효과를 가진다는 보고와 다른 해조류에 항산화 연구와 염색체 이상 억제에 관한 연구는 일부 이루어져 있지만 곰피의 항산화 활성에 관한 연구와 염색체 이상 억제에 관한 연구는 거의 이루어져 있지 않은 상태이다. 따라서, 본 발명의 목적은 곰피 추출물의 용도를 규명하여 식품학적 또는 약학적인 용도로 제공하기 위한 것이다.Gokpi (Ecklonia stolonifera) is a seaweed belonging to the seaweed of seaweed, which belongs to the seaweed, which grows on rocks within 10m of water, and has been used for food for a long time. . In the Gompi, phlorotannin and eclonialactone, such as phloroglucinol, have been isolated and reported. Although there have been reports of anti-cancer effects on Sarcoma-180 cells and studies on antioxidant activity and chromosomal aberration in other seaweeds, there are studies on the antioxidant activity of gompi and the inhibition of chromosomal aberration. Very little research has been done. Therefore, it is an object of the present invention to identify the use of gompi extract to provide food or pharmaceutical use.

본 발명자는 곰피의 메탄올 추출물의 지질과산화에 대한 항산화 효과를 TBA 측정법(TBA assay)에 의해 실험하고, 또한 1,1-디페닐-2-피크릴히드라질(1,1-dipheny1-2picry1hydrazy(DPPH))래티칼에 대한 프리래디칼 소거 효과를 함께 측정한 결과, 곰피의 메탄올 추출물이 지질의 과산화와 프리래디칼의 소거에 대한 항산화작용을 나타내었고, 또한 실험관내(in vitro)염색체 이상 억제실험결과 곰피의 메탄올 추출물이 벤조피렌(benzo(a)pyrene)에 의한 염색체 이상을 80% 정도 억제함을 알수있었다.The present inventors have tested the antioxidant effect on the lipid peroxidation of gompi methanol extract by TBA assay, and also 1,1-diphenyl-2-picrylhydrazyl (1,1-dipheny1-2picry1hydrazy (DPPH) As a result of free radical scavenging effect on radicals, the methanol extract of Gompi showed antioxidant activity on lipid peroxidation and scavenging of free radicals. Blood methanol extract inhibited about 80% of chromosomal aberration caused by benzo (a) pyrene.

이와같이, 본 발명의 곰피의 메탄올 추출물이 항산화활성 및 염색체 이상 억제 작용에 유용한 활성을 가지며, 따라서, 곰피 추출물의 이러한 활성에 의한 신체의 노화방지 및 염색체 이상질환 예방제등으로서의 용도로 유용하다.Thus, the methanol extract of gompi of the present invention has useful activity for antioxidant activity and chromosomal aberration inhibitory activity, and thus, it is useful for use as an anti-aging and chromosomal ailment prevention agent of the body by such activity.

치료목적으로는 이 발명의 추출물과 그것의 제약에 적합한 염들을 경구, 주사 또는 의용제에 적합한 유기 또는 무기, 고체 또는 액체부형제와 같은 제약에 적합한 담체와 혼합되어 활성성분으로서 상기 추출물을 포한하는 제약 제조물의 형태로서 이용될 수 있다. 제약의 제제화는 캡술제, 정제, 당의정, 연고제, 과립, 용액, 현탁액, 에멀젼, 주사제등으로 할 수 있다.For the purpose of treatment, the extract of the present invention and its pharmaceutical salts are mixed with a suitable carrier such as an organic or inorganic, solid or liquid excipient suitable for oral, injection or medicament to contain the extract as an active ingredient. It can be used as a form of preparation. Pharmaceutical formulations can be made with capsulants, tablets, dragees, ointments, granules, solutions, suspensions, emulsions, injections and the like.

필요하다면 이들 제조물들에 보조물질, 안정제, 습윤 혹은 유화제, 완충제 및 기타 통상 사용되는 첨가물들을 포함시킬수 있다.If necessary, these preparations can include auxiliary substances, stabilizers, wetting or emulsifying agents, buffers and other commonly used additives.

본 발명의 추출물의 용량을 환자의 나이나 상태에 따라 변화할수 있지만 유효량으로 평균 1㎎㎎, 2㎎, 5,㎎ 10㎎, 20㎎등이 사용될수 있으며, 1㎎이상이 치료에 효과적이다.The dose of the extract of the present invention can be changed according to the age of the patient, but an effective amount of 1 mgmg, 2mg, 5, mg 10mg, 20mg, etc. can be used, and more than 1mg is effective for treatment.

이하, 본 발명을 실시예에 의하여 상세히 설명하겠지만 본 발명이 이들 실시예에 한정되는 것은 아니다.Hereinafter, although an Example demonstrates this invention in detail, this invention is not limited to these Examples.

[실시예 1]Example 1

[곰피의 메탄올 추출물의 제조방법][Method of Preparing Methanol Extract of Gompi]

곰피의 메탄올 추출물은 미쇄한 건조 곰피(2.9㎏)를 검체로하여 100%메탄올로 상온에서 3회 추출하였다. 추출액을 여과하고 감압농축하여 곰피의 메탄올 추출물(500g)을 얻었다. 이들 곰피의 메탄올 추출물의 최종수율을 다음 표1에 나타내었다.Methanol extract of Gompi was extracted three times at room temperature with 100% methanol using fine dried Gompi (2.9 kg) as a sample. The extract was filtered and concentrated under reduced pressure to obtain a methanol extract of gompi (500 g). The final yield of the methanol extracts of these Gompi is shown in Table 1 below.

[실시예 2]Example 2

[항산화적용]Antioxidant Application

1. TBA측정법(TBA assay)1. TBA assay

곰피로부터 추출한 메탄올 추출물의 항산화 작용의 측정은 생쥐 간 파쇄물(homogenate)의 지질 과산화를 2-티오바비튜르산(2-thiobarbituric acid; TBA)을 이용한 TBA 측정법으로 측정하였다. 즉, 생쥐 간 파쇄물 0.3㎖에 8.1% SDS용액 0.3㎖와 시료용액 0.1㎖을 시험관에 넣고 37℃에서 6시간동안 반응시킨다. 다음 이 반응액에 20% 초산 1.5㎖와 1.2% TBA용액 1㎖를 첨가한후 100 ℃에서 30분간 끓인다. 다음 반응액을 상온에서 냉각시킨후 2500rpm에서 15분간 원심분리후 그 상충액의 흡광도를 532nm에서 측정하여 항산화 효과를 구한다.The antioxidant activity of methanol extract from gompi was measured by TBA assay using 2-thiobarbituric acid (TBA) for lipid peroxidation of mouse liver homogenate. That is, 0.3 ml of mouse liver lysate and 0.3 ml of 8.1% SDS solution and 0.1 ml of sample solution were added to a test tube and reacted at 37 ° C. for 6 hours. Next, 1.5 ml of 20% acetic acid and 1 ml of 1.2% TBA solution were added to the reaction solution and then boiled at 100 ° C. for 30 minutes. Next, the reaction solution was cooled to room temperature, centrifuged at 2500 rpm for 15 minutes, and the absorbance of the supernatant was measured at 532 nm to obtain an antioxidant effect.

흡광도치 0.1을 TBA 1 unit으로하고 간중량 g당 TBA수치로서 지질과산화 정도를 나타내었다. 이 항산화 효과의 측정결과는 다음 표 2와 같다.The absorbance value of 0.1 was defined as 1 TBA unit and the degree of lipid peroxidation was expressed as TBA value per g of liver weight. The measurement results of this antioxidant effect are shown in Table 2 below.

상기표 2에서 알수 있듯이 곰피의 메탄올 추출물은 10㎎/㎖에서 생쥐간 파쇄물의 지질과산화에 대한 항산화효과를 가진다.As can be seen in Table 2, the methanol extract of Gompi has an antioxidant effect on lipid peroxidation of liver decay products at 10 mg / ml.

2.프리래디칼의 소거효과2. Elimination effect of free radical

곰피의 메탄올 추출물의 피리패디칼소거작용의 측정은 여러농도의 시료를 녹인 메탄올 용액 4ml를 1,1-디페닐-2-피크릴히드라질(1.5×10 M)메탄올 용액 1ml를 첨가한후, 상온에서 30분 방치후 520nm에서의 흡광도를 측정하여 프리래디칼 소거작용을 구한다. 이측정결과는 다음 표 3과 같다.The measurement of the pyripadical scavenging effect of the methanol extract of Gompi was carried out using 1 ml of 1,1-diphenyl-2-picrylhydrazyl (1.5 × 10) After adding 1 ml of M) methanol solution, the mixture was left at room temperature for 30 minutes, and then absorbance at 520 nm was measured to determine the free radical scavenging action. The measurement results are shown in Table 3 below.

표 3에서 볼수 있듯이 곰피의 메탄올 추출물은 프리래디칼에 대한 강한 소거작용을 나타내고 있으며 농도에 의존하고 있음을 알 수 있다.As can be seen in Table 3, the methanol extract of Gompi shows strong scavenging effect on free radicals and is dependent on the concentration.

[실시예 3]Example 3

[염색체 이상 억제작용][Inhibition of Chromosome Aberration]

곰피의 메탄올 추출물의 시험관내(in vitro)염색체 이상 억제작용을 다음과 같이 측정하였다. 즉, 차이니즈 햄스터의 폐세포(Chinese hamster lung cell)를 5ml 배지에 초기세포농도 1×10 /ml로 직경 60nm의 페트리디시(Pctri dish)에 키운다. 하루동안 키운 세포에 각 농도의 검체를 투여한 후 S9 혼합액(S9 mix)를 1ml씩 가한다. 6시간 배양후 새배지로 교환한 뒤 다시 18시간을 더 배양하여 총 배양시간이 24시간이 되도록한다. 총배양 22시간에 콜세미드(colcemid)를 첨가하여 2시간 더 배양한후 세포를 수거하여 염색체 이상 유무를 관찰한다. 이때 양성대조물로 벤조피렌(benzo(a)pyrene)을 사용하여 이에 대한 시료의 염색체 이상 억제작용(%)을 구한다.In vitro chromosome aberration inhibitory activity of methanol extract of gompi was measured as follows. In other words, Chinese hamster lung cells (Chinese hamster lung cells) in 5ml medium initial cell concentration 1 × 10 It is grown in a Petri dish having a diameter of 60 nm in / ml. After injecting each concentration sample to the cells grown for one day, 1 ml of S9 mix (S9 mix) is added. After 6 hours of incubation, replace with new medium and incubate another 18 hours so that the total incubation time is 24 hours. After 22 hours of incubation, colcemid was added and cultured for 2 hours. The cells were harvested and observed for chromosomal abnormalities. In this case, benzopyrene (benzo (a) pyrene) is used as a positive control to obtain a chromosome abnormality inhibiting activity (%) of the sample.

표 4에서 볼수 있듯이 곰피의 메탄올 추출물은 125㎍/ml 및 250㎍/ml에서 벤조피렌에 의해 유발되는 염색체 이상에 대한 억제작용이 나타났다.As shown in Table 4, the methanol extract of Gompi showed inhibitory effect on chromosomal aberration caused by benzopyrene at 125 µg / ml and 250 µg / ml.

상기 실시예에 나타난 바와같이 본 발명에 의한 곰피의 메탄올 추출물은 항산화작용과 프리래디칼 소거작용 및 염색체 이상억제작용을 강하게 나타내는 것으로 이들 활성이 뒷받침하는 산화적 손상에 대한 치료제나 염색체 이상 질환의 치료제로 유용한 것이다.As shown in the above examples, the methanol extract of gompi according to the present invention exhibits strong antioxidant activity, free radical scavenging effect and chromosomal aberration inhibitory activity, and is used as a therapeutic agent for oxidative damage supported by these activities or as a therapeutic agent for chromosomal abnormalities. It is useful.

Claims (2)

건조 곰피시료를 메탄올로 추출하여 얻은 곰피 추출물을 주성분으로 하고 여기에 이성화당, 부형제 및 기타 약학적으로 허용되는 첨가물이 첨가될수 있는것임을 특징으로 하는 항산화, 프리래디칼 소거작용제.An antioxidant and free radical scavenging agent, characterized in that isomer extract, excipient and other pharmaceutically acceptable additives may be added as a main ingredient. 건조 곰피시료를 메탄올로 추출하여 얻은 곰피 추출물을 주성분으로하고 여기에 이성화당, 부형제 및 기타 약학적으로 허용되는 첨가물이 첨가될수 있는 것 임을 특징으로 하는 염색체 이상 억제제.A chromosomal abnormality inhibitor, characterized in that isomer extract, excipient and other pharmaceutically acceptable additives can be added to the extract from the dried gompi sample with methanol.
KR1019950043857A 1995-11-27 1995-11-27 Antioxidants and chromosomal disorder inhibitors containing the extracts of ecklonia stolonifera KR0152738B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1019950043857A KR0152738B1 (en) 1995-11-27 1995-11-27 Antioxidants and chromosomal disorder inhibitors containing the extracts of ecklonia stolonifera

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1019950043857A KR0152738B1 (en) 1995-11-27 1995-11-27 Antioxidants and chromosomal disorder inhibitors containing the extracts of ecklonia stolonifera

Publications (2)

Publication Number Publication Date
KR970025623A KR970025623A (en) 1997-06-24
KR0152738B1 true KR0152738B1 (en) 1998-10-15

Family

ID=19435801

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019950043857A KR0152738B1 (en) 1995-11-27 1995-11-27 Antioxidants and chromosomal disorder inhibitors containing the extracts of ecklonia stolonifera

Country Status (1)

Country Link
KR (1) KR0152738B1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100512482B1 (en) * 2003-05-06 2005-09-05 부경대학교 산학협력단 Composition comprising phlorotannins isolated from the extract of Ecklonia stolonifera Okamura having anti-oxidative activity
KR100703597B1 (en) * 2005-06-29 2007-04-16 부경대학교 산학협력단 Composition comprising phlorotannins or the extract of ecklonia stolonifera okamura having hepatoprotective effect on hep g2 cell cytotoxicity induced with tacrine

Also Published As

Publication number Publication date
KR970025623A (en) 1997-06-24

Similar Documents

Publication Publication Date Title
US6524625B2 (en) Physiologically active extract obtained from indigo plant polygonum tinctorium
MX2007005886A (en) Pharmaceutical and therapeutic compositions derived from garcinia mangostana l plant.
KR100926798B1 (en) Antioxidant composition containing hispidin derivatives from the culture broth of fungi Phellinus and Inonotus spp.
KR101946526B1 (en) Composition of preventing or improving UV-induced skin damage comprising hydrangenol
KR0152738B1 (en) Antioxidants and chromosomal disorder inhibitors containing the extracts of ecklonia stolonifera
KR101522596B1 (en) Pharmaceutical Compositions for Prevention or Treatment of Disease Causing Aging of Vascular Endothelial Cell Comprising Extract of Physalis Angulata
WO2022215441A1 (en) Novel polyphenol compound
KR20070024147A (en) Cosmetic composition containing the liposomised asidian tunic extract, having anti-aging effect and anti-wrinkle effect
KR100836941B1 (en) Antioxidants from mushroom inonotus obliquus and composition containing them
JPH11323326A (en) Active oxygen eliminating agent, skin protecting agent and discoloration inhibitor
EP1416927B1 (en) Sesquiterpenoid derivatives having adipocyte differentiation inhibitory effect
EP2441433B1 (en) Olleya marilimosa and its use in a method for the preparation of a composition comprising zeaxanthin
KR20130005118A (en) Pharmaceutical composition for preventing or treating muscle disease and disorders containing sauchinone
KR20190006285A (en) Antibacterial composition comprising an extract of schisandra chinesis
KR20040077158A (en) Antioxidant and chromosome aberration inhibitor consisting of Ecklonia stolonofera extract
KR100191901B1 (en) Novel sesquiterpene ester compound
KR100513430B1 (en) Cosmetic composition containing ginsan polysaccharide extracted from Panax ginseng
WO2009102083A1 (en) Novel clitocybin derivatives, preparation method thereof and composition containing the extract of clitocybe aurantiaca kctc 11143bp or the novel clitocybin derivatives for prevention of aging as an active ingredient
WO2012093919A2 (en) Composition for treating leukemia and method for preparing myrrh extract
EP2133323A1 (en) The production and use of 3,5-dicaffeoyl-4-malonylquinic acid
KR100831757B1 (en) Antioxidants from the culture broth of fungi phellinus and inonotus spp., and composition containing them
US20240139151A1 (en) Composition including decursinol as active ingredient for preventing or treating smooth muscle cell proliferative diseases
KR20010035445A (en) Composition containing extracts from dried roots of Trichosantes kirilowii maxim for external application and skin-whitening and process for preparation thereof
KR101038022B1 (en) A novel sugar compound
KR0182244B1 (en) Pharmaceutical preparations having anticancer activity which include a diaryl heptanoid derivative as an active ingredient

Legal Events

Date Code Title Description
A201 Request for examination
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 20070608

Year of fee payment: 10

LAPS Lapse due to unpaid annual fee